Madame Bioscience PCL (BKK:MADAME)
Thailand · Delayed Price · Currency is THB 0.4800
+0.0200 (4.35%)
At close: May 29, 2026
Madame Bioscience PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -160.62 | 45.77 | -331.63 | -405.81 | -422.31 | -152.43 |
Depreciation & Amortization | 93.67 | 96.94 | 90.75 | 107.02 | 90.33 | 93.68 |
Other Amortization | 0.14 | 0.14 | 0.81 | 0.81 | 1.65 | 1.87 |
Loss (Gain) From Sale of Assets | 80.5 | 80.74 | 2.7 | -0.31 | 22.69 | -14.46 |
Asset Writedown & Restructuring Costs | 13.73 | 17.07 | -1.31 | 198.82 | 26.99 | 127.86 |
Loss (Gain) From Sale of Investments | - | - | 98.01 | - | - | - |
Provision & Write-off of Bad Debts | 67.57 | 67.96 | 0.13 | -0.09 | -1.82 | 2.54 |
Other Operating Activities | -365.89 | -316.08 | 279.56 | 53.4 | 44.07 | -19.27 |
Change in Accounts Receivable | 278.05 | 106.8 | -4.34 | -28.24 | 74.36 | -76.52 |
Change in Inventory | 54.53 | 95.48 | 72.63 | 50.92 | 95.04 | -122.61 |
Change in Accounts Payable | -85.46 | -156.89 | 13.64 | 71.79 | -79.54 | 139.08 |
Change in Other Net Operating Assets | 19.98 | -3.26 | 6.06 | 23.68 | -16.12 | -77.85 |
Operating Cash Flow | 1.23 | 39.72 | 227.01 | 71.98 | -163.44 | -98.48 |
Operating Cash Flow Growth | -99.33% | -82.50% | 215.36% | - | - | - |
Capital Expenditures | -42.74 | -41.49 | -15.39 | -39.61 | -144.02 | -206.38 |
Sale of Property, Plant & Equipment | 2.37 | 4.39 | 1.41 | 6.74 | 0.17 | 1.41 |
Cash Acquisitions | -160.46 | -160.46 | - | - | -484.08 | - |
Divestitures | - | - | - | - | - | 84.43 |
Investment in Securities | 0.2 | - | - | - | - | - |
Other Investing Activities | 16.98 | 17.45 | 1.73 | -84.9 | -27.78 | - |
Investing Cash Flow | -183.64 | -180.1 | -12.25 | -117.77 | -655.71 | -120.53 |
Short-Term Debt Issued | - | 389.29 | - | - | 58.43 | 628.62 |
Long-Term Debt Issued | - | 301.75 | 9.89 | - | 386.11 | 135.08 |
Total Debt Issued | 721.39 | 691.04 | 9.89 | - | 444.54 | 763.7 |
Short-Term Debt Repaid | - | -437.45 | -1.96 | -34.86 | - | -598.89 |
Long-Term Debt Repaid | - | -275.45 | -205.73 | -83.49 | -21.77 | -47.33 |
Total Debt Repaid | -711.65 | -712.91 | -207.69 | -118.36 | -21.77 | -646.22 |
Net Debt Issued (Repaid) | 9.74 | -21.87 | -197.8 | -118.36 | 422.76 | 117.48 |
Issuance of Common Stock | 116.16 | 116.16 | 73.83 | - | 646.27 | 103.28 |
Other Financing Activities | 142.39 | 136.16 | -44.94 | -54.22 | -38.45 | -60.31 |
Financing Cash Flow | 268.29 | 230.45 | -168.9 | -172.57 | 1,031 | 160.45 |
Net Cash Flow | 85.88 | 90.07 | 45.85 | -218.35 | 211.43 | -58.56 |
Free Cash Flow | -41.5 | -1.77 | 211.62 | 32.37 | -307.46 | -304.86 |
Free Cash Flow Growth | - | - | 553.65% | - | - | - |
Free Cash Flow Margin | -2.72% | -0.12% | 9.97% | 1.41% | -13.80% | -16.37% |
Free Cash Flow Per Share | -0.05 | -0.00 | 0.34 | 0.05 | -0.51 | -0.76 |
Cash Interest Paid | 37.76 | 37.76 | 44.94 | 54.22 | 38.45 | 10.31 |
Cash Income Tax Paid | 2.68 | 2.68 | 1.15 | 0.83 | 14.46 | 3.98 |
Levered Free Cash Flow | 60.1 | 41.08 | 184.59 | 50.55 | -216.02 | -315.95 |
Unlevered Free Cash Flow | 76.5 | 61.52 | 216.42 | 88.74 | -189.69 | -309.35 |
Change in Working Capital | 267.1 | 42.14 | 87.98 | 118.15 | 73.73 | -137.9 |